VZR-20770-43441 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-28
Registered in v-safe
2021-01-28
Dose 1 — Pfizer-BioNTech
2021-01-28
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2022-01-28
Survey response — 12 months, dose 1
MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid symptoms, sore throat

MedDRA releases: 2024-11 · check-in free text available
2022-01-28
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-01
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-28	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-28	Unsuccessful

Free text

Release 11 — 12 months, dose 1

2022-01-28

Symptoms: Covid symptoms, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release